Riverwater Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,927
| Closed | -$277K | – | 215 |
|
|
2025
Q1 | $277K | Buy |
10,927
+817
| +8% | +$20.7K | 0.14% | 170 |
|
|
2024
Q4 | $268K | Sell |
10,110
-31
| -0.3% | -$822 | 0.13% | 187 |
|
|
2024
Q3 | $290K | Sell |
10,141
-161
| -2% | -$4.61K | 0.14% | 169 |
|
|
2024
Q2 | $288K | Sell |
10,302
-120
| -1% | -$3.36K | 0.21% | 143 |
|
|
2024
Q1 | $289K | Sell |
10,422
-199
| -2% | -$5.52K | 0.21% | 151 |
|
|
2023
Q4 | $306K | Sell |
10,621
-1,644
| -13% | -$47.3K | 0.24% | 134 |
|
|
2023
Q3 | $407K | Buy |
12,265
+386
| +3% | +$12.8K | 0.37% | 84 |
|
|
2023
Q2 | $436K | Buy |
11,879
+23
| +0.2% | +$844 | 0.39% | 77 |
|
|
2023
Q1 | $484K | Sell |
11,856
-778
| -6% | -$31.7K | 0.44% | 68 |
|
|
2022
Q4 | $647K | Sell |
12,634
-274
| -2% | -$14K | 0.55% | 56 |
|
|
2022
Q3 | $565K | Buy |
12,908
+91
| +0.7% | +$3.98K | 0.56% | 57 |
|
|
2022
Q2 | $672K | Buy |
12,817
+44
| +0.3% | +$2.31K | 0.68% | 40 |
|
|
2022
Q1 | $661K | Buy |
12,773
+198
| +2% | +$10.2K | 1.09% | 37 |
|
|
2021
Q4 | $743K | Buy |
+12,575
| New | +$743K | 0.66% | 44 |
|